GlobeNewsWire
24 Jul 2026, 10:36 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Insulet disclosed manufacturing defects in Omnipod 5, DASH, and Eros systems involving torn tubing that could lead to insulin under-delivery. — Fundamental product safety failures and recurring medical device corrections directly threaten revenue, market share, and patient safety.
-0.80A securities fraud class action lawsuit has been filed against Insulet and its executives for allegedly misrepresenting product safety and manufacturing capabilities. — Litigation creates significant legal liabilities and indicates potential management credibility issues that can depress stock valuation.
-0.50Insulet's stock price experienced two significant drops, including a 6.88% decline in March and a subsequent sharp fall in May following device correction announcements. — The price action confirms that the market has already begun pricing in the negative news, reducing the 'shock' value of the lawsuit itself.
-0.30Continue reading
6 related stories
Search tags
Which stocks this story touches
The company is facing a securities fraud class action lawsuit following manufacturing defects and significant stock price drops.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
11h ago
